Drug Shortage Report for LUVERIS

Last updated on 2018-06-09 History
Report ID 50104
Drug Identification Number 02269066
Brand name LUVERIS
Common or Proper name Lutropin Alpha for injection
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA
Market Status MARKETED
Active Ingredient(s) LUTROPIN ALFA
Strength(s) 75UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1 x 75 IU vial
ATC code G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-28
Estimated end date
Actual end date 2018-06-08
Shortage status Resolved
Updated date 2018-06-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2695 NORTH SHERIDAN WAY, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5K 2N6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-06-09 English Compare
v10 2018-06-08 French Compare
v9 2018-06-08 English Compare
v8 2018-05-29 English Compare
v7 2018-05-28 French Compare
v6 2018-05-28 English Compare
v5 2018-05-28 French Compare
v4 2018-05-28 English Compare
v3 2018-05-23 French Compare
v2 2018-05-23 English Compare
v1 2018-05-23 English Compare

Showing 1 to 11 of 11